Angiogenic activity in sera of patients with systemic lupus erythematosus
- 5 June 2009
- journal article
- research article
- Published by SAGE Publications in Lupus
- Vol. 18 (8), 705-712
- https://doi.org/10.1177/0961203309103087
Abstract
Angiogenesis plays a critical role in the pathogenesis of several connective tissue diseases. There is, however, relatively little information available on the role of angiogenesis in systemic lupus erythematosus (SLE). The aim of this study was to investigate the angiogenic activity in sera of patients with SLE and to determine the association between angiogenic activity and clinical complications. Sera from 66 Tunisian females with SLE and from 32 healthy blood donors were studied for their angiogenic activity using the in-vitro tube formation test on Matrigel. Samples were divided into five groups according to their angiogenic activity, which was scored from 0 (no angiogenesis) to 4 (high angiogenic activity). Samples from each group were then tested randomly to assess serum concentration of vascular endothelial growth factor (VEGF). No correlation was found between angiogenic activity scores and serum VEGF levels. Considering angiogenesis assessment in-vitro, sera of patients with SLE showed a much higher angiogenic activity than healthy controls since a high angiogenic score (score 4) is present in 43.9% of patients and in 6.3% of controls ( P < 0.0002). This high angiogenic activity is not correlated with disease activity; however, SLE patients with anti-dsDNA antibodies and those with nephritis showed higher angiogenic activity compared with patients without these complications since score 4 is found in 50.9% and 67.9% versus 9.1% ( P = 0.017) and 26.3% ( P < 0.001), respectively. In conclusion, our study showed that high serum angiogenic activity in SLE was not correlated with the VEGF levels. We suggest the use of the ‘in-vitro’ tube formation test as a better tool to study the angiogenic potential of sera. We found that in patients with SLE, serum angiogenic activity is increased compared with healthy controls. This high angiogenic activity is associated with renal complications and with the presence of anti-dsDNA antibodies. These findings suggest an involvement of angiogenesis disturbance in the pathogenesis of SLE.Keywords
This publication has 38 references indexed in Scilit:
- p73 isoforms affect VEGF, VEGF165b and PEDF expression in human colorectal tumors: VEGF165b downregulation as a marker of poor prognosisInternational Journal of Cancer, 2008
- Serum levels of vascular endothelial growth factor in children and adolescents with systemic lupus erythematosusPediatric Allergy and Immunology, 2007
- Biology of vascular endothelial growth factorsFEBS Letters, 2006
- Effect of Human Anti-DNA Antibodies on Proximal Renal Tubular Epithelial Cell Cytokine ExpressionJournal of the American Society of Nephrology, 2005
- Circulating angiogenesis inhibitor endostatin and positive endothelial growth regulators in patients with systemic lupus erythematosusLupus, 2002
- Monoclonal anti‐double stranded DNA antibody is a leucocyte‐binding protein to up‐regulate interleukin‐8 gene expression and elicit apoptosis of normal human polymorphonuclear neutrophilsRheumatology, 2001
- Clinical significance of the determination of angiogenic factorsEuropean Journal of Cancer, 1996
- Serum concentrations of basic fibroblast growth factor in collagen diseasesJournal of the American Academy of Dermatology, 1996
- Patterns and Emerging Mechanisms of the Angiogenic Switch during TumorigenesisCell, 1996
- Derivation of the sledai. A disease activity index for lupus patientsArthritis & Rheumatism, 1992